Transmission of ESBL-producing Enterobacteriaceae
NCT03465683 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2025-11-17
Summary
The aim of this research project is to investigate the transmission of ESBL-producing Enterobacteriaceae on both, the level of bacterial strains and mobile genetic elements, and to determine the source of hospital-acquired infections.
Conditions
- Hospital Acquired Infection
Interventions
- OTHER
-
ESBL-producing Enterobacteriaceae
Data and biological sample collection
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Sarah Tschudin-Sutter, PD MD · Division of Infectious Disease and Hopital Epidemiology, University Hospital Basle
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-01
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Fecal ESBL Resurgence During Antibiotic Treatment
NCT03206879 ·Status: TERMINATED
-
Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli
NCT04764500 ·Status: ACTIVE_NOT_RECRUITING
-
Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria
NCT06910878 ·Status: RECRUITING
-
Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection
NCT04131569 ·Status: UNKNOWN
-
Infections Caused by ESbL-Producing Enterobacteriaceae in Italy
NCT00404625 ·Status: UNKNOWN
-
Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae
NCT04903886 ·Status: UNKNOWN
-
Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes.
NCT03248999 ·Status: COMPLETED ·Phase: NA
-
Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms
NCT01324726 ·Status: COMPLETED
-
Extended Spectrum Betalactamase Producing Bacteria; Epidemiology and Treatment in Non-hospitalized Patients
NCT01838213 ·Status: COMPLETED
-
Prognostic Factors and Therapeutic Management of ESBL Enterobacteriaceae in the ICU
NCT05833282 ·Status: UNKNOWN
-
Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria
NCT03338738 ·Status: COMPLETED ·Phase: NA
-
Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalosporinase (HLC) on the Risk of Infections With C3G-resistant Enterobacteria
NCT07345923 ·Status: RECRUITING
-
Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Change
NCT01392118 ·Status: UNKNOWN
-
Epidemiology of ST131 in Besançon University Hospital
NCT02853708 ·Status: COMPLETED
-
From Commensalism to Pathogenicity: Exploring the Pathophysiology of Bacteremia to Better Understand Enterococcus Faecalis Infective Endocarditis
NCT07313865 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum RC15_0421
NCT02847065 ·Status: COMPLETED
-
Community - Associated Extended-spectrum Beta-lactamases (ESBL)
NCT00363220 ·Status: COMPLETED
-
Clinical Trial to Reduce Antibiotic Resistance in European Intensive Cares
NCT00976638 ·Status: COMPLETED ·Phase: NA
-
Epidemiology of Resistant Microbial Strains Among Different Groups of People (Healthy, Infected and Exposed to Animals)
NCT03343119 ·Status: UNKNOWN
-
Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital
NCT04098133 ·Status: RECRUITING
-
A Multicentre Study of Wastewater and Antibiotic Resistance in Care Homes.
NCT07234331 ·Status: RECRUITING
-
Effects of H.Pylori Eradication on Microbiome
NCT03231332 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Multi-resistant Enterobacteriaceae Colonisation in Less Than 32 Weeks Pregnant Women Admitted to the Hospital.
NCT02631226 ·Status: UNKNOWN
-
Factors Influencing the Fecal Relative Abundance of ESBL-producing Enterobacteriaceae in Intensive Care (BLSE-REA).
NCT04190316 ·Status: UNKNOWN ·Phase: NA
-
Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
NCT06833593 ·Status: RECRUITING